Recall of Infant Formula Linked to Cronobacter sakazakii and Salmonella Newport

Infant Formula Linked to Cronobacter sakazakii and Salmonella Newport


The U.S. Food and Drug Administration (FDA), along with the Centers for Disease Control and Prevention (CDC), are investigating four consumer complaints of infant illness received from September 20, 2021, to January 11, 2022, related to infant formula products from the Abbott Nutrition facility in Sturgis, MI. All of the cases are reported to have consumed powdered infant formula produced at this facility. These complaints include three reports of Cronobacter sakazakii infections and one report of Salmonella Newport infection in infants. All four cases related to these complaints were hospitalized, and Cronobacter infection may have contributed to death in one case.

The Indiana Department of Health (IDOH) is issuing a call for cases of Cronobacter sakazakii and Salmonella Newport that could be associated with powdered infant formula. Please notify the IDOH Enteric Epidemiology Team of any Cronobacter sakazakii or Salmonella cases among infants who consumed powdered infant formula in the 10 days before illness onset. Onset dates are estimated to range from November 2020 to the present date. No Indiana cases of Cronobacter sakazakii or Salmonella linked to recalled infant formula have been identified at this time. Testing of recalled infant formula samples may be approved if criteria are met.

Please review the links in this PDF file for more information about a recall of infant formula due to potential bacterial contamination, including Cronobacter sakazakii or Salmonella species.